IFM Therapeutics
PrivateLast Round
VC Round
Dec 2, 2019
Total Funding Raised
$58M
Company Overview
IFM Therapeutics is a biopharmaceutical company that develops small molecule medicines aimed at enhancing immunotherapy by precisely targeting the innate immune system to address complex issues in treating inflammatory and autoimmune disorders as well as cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IFM Therapeutics Comparables
Compare IFM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ventus Therapeutics | 89% | |
| Olatec Therapeutics | 86% | |
| Inflammasome Therapeutics | 81% |
IFM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 2, 2019 | ||||
| Series A | Jul 19, 2018 | ||||
| M&A | Aug 3, 2017 | ||||
| Series A | Jun 21, 2016 | ||||
| Seed | Oct 1, 2015 |
Key People
Founding team and executive leadership
IFM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | VC Round |
| Abingworth | Series A, VC Round |
| Atlas Venture | Series A, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2019
$56M round led by Omega Funds.
- Jul 19, 2018
$31M round with participation from Abingworth and Atlas Venture.
IFM Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about IFM Therapeutics's valuation, stock price, and market status.
Is IFM Therapeutics a public or private company?
IFM Therapeutics is a private company.
What is the current stock price of IFM Therapeutics?
IFM Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is IFM Therapeutics worth (valuation)?
Valuation information for IFM Therapeutics is not publicly available.
Can I buy IFM Therapeutics stock?
IFM Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was IFM Therapeutics's last funding round?
IFM Therapeutics's most recent funding round was Series B on December 2, 2019.
Who are the main investors in IFM Therapeutics?
Key investors in IFM Therapeutics include Omega Funds, Abingworth, Atlas Venture.
Will IFM Therapeutics IPO soon?
No public IPO plans have been announced for IFM Therapeutics.
How can I track IFM Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IFM Therapeutics's secondary market activity and sign up for updates.